Encouraging and funding research into iron overload.
Scientific research into iron overload and its treatment is ongoing worldwide. Haemochromatosis UK has a small research budget which the trustees can apply, after consulting our scientific advisers, to support research in the UK.
Academic research papers are written primarily for professionals and are not always easy reading for lay persons. However if you search “haemochromatosis” into Google Scholar, you can get read some papers about GH.
The Society works with the scientific community to support and encourage research into genetic haemochromatosis, and provides small grants to tackle basic scientific, treatment or social issues that affect patients with haemochromatosis.
Grants to fund projects that investigate the prevalence and penetrance of haemochromatosis will also be considered.
Applying for a grant
Grant proposals are accepted at anytime from researchers working in recognised institutions in the UK. Suitable applications progress to peer-review and a decision as to whether to fund a project is made at the earliest possible quarterly board meeting.
Approval by our scientific advisers and strong recommendations from peer review does not in itself guarantee approval. Trustees will also consider the availability of finance and the alignment of any project with the charity’s strategic objectives.
Researchers can apply for a grant using the application from which is available to download below. You must also download and read the terms and conditions of any grant we agree.
>> Download Haemochromatosis Grant Application Form (April 2015) (.docx)
>> Download Terms and Conditions for the Awarding of Research Grants (April 2015) (.pdf)
Applications should be submitted by email to email@example.com.
Preliminary enquiries about potential projects, questions about the grant process and enquiries about the progress of any particular application should be directed to the same email address.
Please note that the charity relies on the goodwill of eminent scientists and clinicians who provide advice and guidance on a purely pro-bono basis and therefore responses may not be immediate.
Information about Clinical Trials
Increasingly Haemochromatosis UK and haemochromatosis patients are taking an interest in the world of medical research. Just what does the future hold? Prospects for alternative treatments and treatment pathways are just beginning to emerge. Read below to take a look at the world of the clinical trials.